Published in Clin Chem Lab Med on December 20, 2011
Comparison of Seegene Anyplex II HPV28 with the PGMY-CHUV assay for human papillomavirus genotyping. J Clin Microbiol (2013) 0.95
Clinical validation of a type-specific real-time quantitative human papillomavirus PCR against the performance of hybrid capture 2 for the purpose of cervical cancer screening. J Clin Microbiol (2012) 0.93
Association of Trichomonas vaginalis and cytological abnormalities of the cervix in low risk women. PLoS One (2013) 0.92
Changes in type-specific human papillomavirus load predict progression to cervical cancer. J Cell Mol Med (2012) 0.92
Simultaneous detection, genotyping, and quantification of human papillomaviruses by multicolor real-time PCR and melting curve analysis. J Clin Microbiol (2012) 0.83
Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections. Cancer Med (2015) 0.81
Long-Term Follow-up of HPV Infection Using Urine and Cervical Quantitative HPV DNA Testing. Int J Mol Sci (2016) 0.79
Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests). J Clin Microbiol (2016) 0.79
Prevalence of high-risk human papillomavirus and abnormal pap smears in female sex workers compared to the general population in Antwerp, Belgium. BMC Public Health (2016) 0.78
Distribution of human papillomaviruses and bacterial vaginosis in HIV positive women with abnormal cytology in Mombasa, Kenya. Infect Agent Cancer (2016) 0.76
Association of HIV infection with distribution and viral load of HPV types in Kenya: a survey with 820 female sex workers. BMC Infect Dis (2010) 1.35
Epsin: inducing membrane curvature. Int J Biochem Cell Biol (2007) 1.07
Mechanisms of cell entry by human papillomaviruses: an overview. Virol J (2010) 1.04
Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope (2012) 1.00
Human papillomavirus 16 load and E2/E6 ratio in HPV16-positive women: biomarkers for cervical intraepithelial neoplasia >or=2 in a liquid-based cytology setting? Cancer Epidemiol Biomarkers Prev (2009) 0.99
High incidence of high-risk HPV in benign and malignant lesions of the larynx. Int J Oncol (2011) 0.98
Immunocytochemistry in liquid-based cervical cytology: analysis of clinical use following a cross-sectional study. Int J Cancer (2006) 0.97
Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation. Int J Cancer (2011) 0.97
Prior knowledge of HPV status improves detection of CIN2+ by cytology screening. Am J Obstet Gynecol (2011) 0.95
Changes in type-specific human papillomavirus load predict progression to cervical cancer. J Cell Mol Med (2012) 0.92
P16INK4a as an adjunct marker in liquid-based cervical cytology. Int J Cancer (2004) 0.89
The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity. PLoS One (2013) 0.89
Nucleic acid sequence-based amplification assay for human papillomavirus mRNA detection and typing: evidence for DNA amplification. J Clin Microbiol (2010) 0.87
Role of protein biomarkers in the detection of high-grade disease in cervical cancer screening programs. J Oncol (2012) 0.87
Combined analysis of HPV DNA, p16, p21 and p53 to predict prognosis in patients with stage IV hypopharyngeal carcinoma. J Cancer Res Clin Oncol (2010) 0.84
BD-ProExC as adjunct molecular marker for improved detection of CIN2+ after HPV primary screening. Cancer Epidemiol Biomarkers Prev (2011) 0.84
Don't forget HPV-45 in cervical cancer screening. Am J Clin Pathol (2012) 0.82
Detection and quantification of human papillomavirus in benign and malignant parotid lesions. Anticancer Res (2012) 0.81
Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment. Am J Physiol Renal Physiol (2011) 0.81
High prevalence of high-risk human papillomavirus in palatine tonsils from healthy children and adults. Otolaryngol Head Neck Surg (2011) 0.79
Serial measurement of type-specific human papillomavirus load enables classification of cervical intraepithelial neoplasia lesions according to occurring human papillomavirus-induced pathway. Eur J Cancer Prev (2017) 0.78
Anal human papillomavirus DNA in women at a colposcopy clinic. Eur J Obstet Gynecol Reprod Biol (2012) 0.78
Stromal issues in cervical cancer: a review of the role and function of basement membrane, stroma, immune response and angiogenesis in cervical cancer development. Eur J Cancer Prev (2010) 0.78
Quality control for normal liquid-based cytology: rescreening, high-risk HPV targeted reviewing and/or high-risk HPV detection? J Cell Mol Med (2008) 0.77
Human papillomavirus predicts the outcome following concomitant chemoradiotherapy in patients with head and neck squamous cell carcinomas. Oncol Rep (2013) 0.76
Relationship between seminal plasma-soluble transferrin receptor and spermatogenesis in azoospermic patients. Fertil Steril (2003) 0.75
Myopathy with hexagonally cross-linked crystalloid inclusions: delineation of a clinico-pathological entity. Neuromuscul Disord (2010) 0.75
Biomarkers in cervical screening: quantitative reverse transcriptase PCR analysis of P16INK4a expression. Eur J Cancer Prev (2010) 0.75